AI assistant
Sending…
IMMUNIC, INC. — Director's Dealing 2014
Apr 23, 2014
10196_dirs_2014-04-23_a0d13904-8ea7-4203-959d-e52660d22d02.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VITAL THERAPIES INC (VTL)
CIK: 0001280776
Period of Report: 2014-04-23
Reporting Person: Halperin Errol R. (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-04-23 | Common Stock | P | 8333 | $12.00 | Acquired | 8333 | Indirect |
| 2014-04-23 | Common Stock | P | 6191 | $12.00 | Acquired | 6191 | Indirect |
| 2014-04-23 | Common Stock | C | 39417 | — | Acquired | 45608 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-04-23 | Senior Convertible Preferred Stock | $ | C | 39417 | Disposed | Common Stock (39417) | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 40000 | Direct |
Footnotes
F1: Shares held by Errol Halperin IRA FBO Errol Halperin
F2: Each share of Senior Convertible Preferred Stock automatically converted into the Registrant's common stock on a one-for-one basis immediately prior to the closing of the Registrant's initial public offering and had no expiration date.
More from IMMUNIC, INC.
Regulatory Filings
2026
May 28
Board/Management Information
2026
May 27
Board/Management Information
2026
May 19
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 13
Earnings Release
2026
May 13
Regulatory Filings
2026
Apr 30
Board/Management Information
2026
Apr 28
Board/Management Information
2026
Apr 28
Share Issue/Capital Change
2026
Apr 23